Neurological Disorder Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Neurological Disorder Drugs Market is Segmented by Disorders (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, and Other Disorders), Drug Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic & Antidepressant, and Other Drugs Type), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Neurological Disorder Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Neurological Disorder Drugs Industry Overview

The neurological disorder drugs market is fragmented, competitive and consists of several major players. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well-known including Merck & Co., Inc, AstraZeneca, Abbott, F. Hoffmann-La Roche Ltd., and Novartis AG.

Neurological Disorder Drugs Market Leaders

  1. Pfizer Inc

  2. Bayer AG

  3. Johnson & Johnson Private Limited

  4. Novartis AG

  5. F. Hoffmann-La Roche Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
Neurological Disorder Drugs Market Concentration